Healthcare

ARG-007 is being developed as a neuroprotective candidate rather than an established treatment. The research programme investigates whether the peptide can reduce the cellular injury that occurs when brain tissue experiences an interruption in blood supply. Acute ischaemic stroke involves a blocked blood vessel, …

ALA-101 is designed to draw on two elements of immune-cell recognition. The engineered CAR targets CD19-positive cells, while the underlying iNKT cell retains its natural immune-recognition functions. This differs from conventional patient-specific CAR-T manufacturing, which requires cells to be collected and modified separately for …

The company describes Gastrointestinal ReProgramming (GaRP) as a multicomponent, multicoated complementary medicine designed to address factors associated with irritable bowel syndrome (IBS) and related gastrointestinal disorders. Anatara Lifesciences (ASX:ANR) says the formulation is intended to support the gut lining and help maintain balance in …

The extracellular matrix is the structural framework surrounding cells in living tissue. Aroa’s approach uses a processed biological scaffold intended to support the body’s tissue repair processes. Its underlying technology is used across products for wound treatment and soft tissue reconstruction, where clinicians must …

AdAlta Limited (ASX:1AD) is an Australian clinical-stage biotechnology company developing cellular immunotherapies for solid cancers and medicines based on its proprietary i-body technology. Its 2026 activities include advancing the EW-001 cell-therapy program while seeking partners for the AD-214 anti-fibrotic candidate. The distinction matters because …

In an ASX announcement dated 28 April 2026, Acrux Limited (ASX:ACR) said its new strategy followed a business review covering existing US generic products, development candidates, regulatory developments in hormone treatment and internal research capabilities. Rather than concentrate solely on topical generics, the company …

TPM combines proprietary forms of tocopheryl phosphate derived from vitamin E. According to Avecho, the material forms small particles capable of containing drug molecules, which can improve solubility and assist absorption. The company describes potential applications across oral, dermal and transdermal formulations. They do …